These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4913864)

  • 1. Biological activity of drugs. XI. Relation of structure to the bacteriostatic activity of sulfonamides. (2).
    Morishita T; Yamazaki M; Kakeya N; Kamada A; Aoki M
    Chem Pharm Bull (Tokyo); 1970 Apr; 18(4):708-14. PubMed ID: 4913864
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activity of drugs. X. Relation of structure to the bacteriostatic activity of sulfonamides. (1).
    Yamazaki M; Kakeya N; Morishita T; Kamada A; Aoki M
    Chem Pharm Bull (Tokyo); 1970 Apr; 18(4):702-7. PubMed ID: 4913863
    [No Abstract]   [Full Text] [Related]  

  • 3. Spectroscopic studies on molecular interactions. IV. Charge-transfer properties and antibacterial activity of sulfonamides.
    Moriguchi I; Kaneniwa N
    Chem Pharm Bull (Tokyo); 1969 Dec; 17(12):2554-7. PubMed ID: 4906828
    [No Abstract]   [Full Text] [Related]  

  • 4. Physical parameters and biological activity of sulfonamides.
    Avico U; Zuccaro P; Cingolani E; Ciranni Signoretti E
    Farmaco Sci; 1985 Dec; 40(12):970-8. PubMed ID: 4092768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution on the synthesis as well as on the knowledge of the physical-chemical and bacteriological behavior of fusaric acid esters].
    Vogt H; Mayer H
    Arzneimittelforschung; 1968 Feb; 18(2):207-11. PubMed ID: 4876968
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative structure-pharmacokinetic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships.
    Seydel JK; Trettin D; Cordes HP; Wassermann O; Malyusz M
    J Med Chem; 1980 Jun; 23(6):607-13. PubMed ID: 6993682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the microbiological indefectibility of sulfonamides. Disruption of the bacteriostatic effect].
    Ludva J; Gajdos M
    Cesk Farm; 1978 Apr; 27(3):143-5. PubMed ID: 99248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthesis and preliminary test of two sulfonamides with trifluoromethyl groups].
    Dingeldein E; Hald H; Zimmer G
    Arzneimittelforschung; 1971 Apr; 21(4):571-3. PubMed ID: 4928862
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in sulfonamide research.
    Struller T
    Prog Drug Res; 1968; 12():389-457. PubMed ID: 4893676
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation between structure of sulphonamides and inhibition of H2-pteroate synthesis in Escherichia coli.
    Thijssen HH
    J Pharm Pharmacol; 1974 Apr; 26(4):228-34. PubMed ID: 4151377
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of sulphonamides as a function of their molar refractivity.
    Kaliszan R; Osmialowski K; Kobylczyk K
    Chemotherapy; 1979; 25(1):5-8. PubMed ID: 369784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological implications of molecular and crystal structures of sulfadimethoxine, sulfadoxine, and sulfisoxazole.
    Shefter E; Chmielewicz ZF; Blount JF; Brennan TF; Sackman BF; Sackman P
    J Pharm Sci; 1972 Jun; 61(6):872-7. PubMed ID: 4558258
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of blood glucose lowering sulfonamides].
    Krüger-Thiemer E; Bünger P; Seydel JK
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():74-104. PubMed ID: 4906027
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antibacterial effect of the non-protein-bound part of sulfonamides in human plasma].
    Krüger-Thiemer E; Wempe E; Töpfer M
    Arzneimittelforschung; 1965 Nov; 15(11):1309-17. PubMed ID: 4961879
    [No Abstract]   [Full Text] [Related]  

  • 15. Spectroscopic studies of some Schiff bases derived from sulphonamides and their biological activity uses.
    el-Ries MA; Abu-el-Wafa SM; el-Kousy SM
    J Pharm Belg; 1988; 43(2):93-9. PubMed ID: 3411431
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relations between physical parameters and biological activity of organic substances. I. Solubility in water of the amorphous phase of some sulfonamides].
    Avico U; Cavazzutti G; Di Francesco R; Signoretti Ciranni E; Zuccaro P
    Farmaco Prat; 1975 Jan; 30(1):40-6. PubMed ID: 1183572
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and antibacterial properties of 4-sulfonamidopyrimidine derivatives.
    Cieplik J; Pluta J; Gubrynowicz O
    Acta Pol Pharm; 2003; 60(1):75-9. PubMed ID: 12848371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the cross resistance of bacteria to sulfonamides. 3. The behavior of bacteria toward sulfonamides substituted in N1 with an acyl, carbamyl, thiocarbamyl or guanidyl group].
    Patsch R; Höhne C
    Zentralbl Bakteriol Orig; 1967 Jan; 202(2):227-32. PubMed ID: 4970772
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental studies on the effect of elkosin on the H2S splitting by Escherichia coli bacteria].
    TANNERT S
    Z Gesamte Inn Med; 1952 Nov; 7(22):1042-6. PubMed ID: 13039339
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
    Anton AH
    Ann N Y Acad Sci; 1973 Nov; 226():273-92. PubMed ID: 4588442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.